Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
A quick evaluation of altcoin teams in 2024, focusing on development cadence, leadership experience, and past deliverables.
27,759 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Tech stocks led the rebound as tensions eased, lifting the Nasdaq while broad indices followed. Here’s what happened,...
Kick off your week with a concise, practical set of market notes. This Tuesday reads guide blends data, strategy, and...
With Broadcom set to report earnings, investors are weighing momentum in AI infrastructure against valuation. This gu...
A major AI feature sparked controversy in the writing world. Grammarly paused its 'Expert Review' tool after authors ...
A small, steady rental portfolio can fuel early retirement. This article breaks down a boring, proven path to retire ...
A rare diana throwback feels moment went viral, turning emotion into a money lesson. This guide shows you how to budg...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Hormel (HRL) 2026 earnings continue to show resilience in a volatile consumer environment. This deep dive breaks down...
Public moments shape wealth, influence, and financial strategy. This article turns the jack schlossberg line madonna’...
A remote Canadian worksite faced a rare black bear incident that claimed a contractor's life. This article uses the t...